UNSPSC 51202503: Procodazole

This classification denotes a biological response modifier with the molecular formula C10H10N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) SG5IU7FD3R, chemically known as propionic acid, 2-(2-benzimidazolyl)- but more generally known as procodazole, which bears US NIH Compound Identifier 65708. European Medicines Agency schedules Procodazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10063MIG.

UNSPSC 51202503 Procodazole is a Commodity code that nominally addresses a specific pharmaceutical product, but recent state and local opportunities tagged under this code solicitation diverge significantly from the code's narrow scope. The most recently posted opportunities involve procurement of naloxone and drug deactivation systems, medical and first aid supplies for emergency response, generic multi-source pharmaceuticals and OTC products through cooperative purchasing, and exploratory market intelligence on direct-to-manufacturer pharmacy programs—none of which map directly to procodazole specifically. State and local buyers using this code are sourcing broader pharmaceutical categories, medical supplies, and pharmacy benefit program infrastructure rather than a single active pharmaceutical ingredient. Issuing bodies include county health departments (Seminole County, Florida), municipal fire rescue services (City of Tampa), state health and human services commissions (Texas HHS), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, or MMCAP). The code sees use across jurisdictions managing public health, emergency medical services, and pharmacy benefit programs serving state and local employees and beneficiaries.

Geographic activity is concentrated in Florida, Texas, and Minnesota based on recent postings, with the MMCAP RFP extending to participating states including Oregon. Representative opportunities include Seminole County's IFB 60459723LAS (posted June 30, 2026, due July 26, 2023—note date discrepancy in source) for 1,900 units of naloxone and 800 drug deactivation systems annually; the City of Tampa's ITB 26P00145 (posted March 25, 2026, due March 13, 2026) for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, with an estimated contract value of $700,000 and a 5% bid discount reserved for certified Small Local Business Enterprises; and Minnesota's MMCAP RFP S1070000015802 (posted January 20, 2026, due March 26, 2026) establishing multiple-award contracts for generic pharmaceuticals and OTC products distributed through three authorized wholesalers. The Texas HHS RFI HHS0017013 (posted April 3, 2026) represents early-stage market intelligence gathering on direct-to-manufacturer pharmacy programs. Cooperative purchasing vehicles and small-business set-asides appear in multiple solicitations, particularly the Tampa SLBE sheltered-market opportunity.